Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion
NCT ID: NCT05807984
Last Updated: 2023-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE2
31 participants
INTERVENTIONAL
2023-05-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer
NCT07297004
MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer
NCT03714490
Short Course or Long Course Radiotherapy as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT07258797
Preoperative (Chemo)Radiotherapy for Locally Recurrent Rectal Cancer
NCT06617052
Intersphincteric Resection With or Without Intraoperative Radiation in Rectal Cancer
NCT03393234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
carbon ion therapy for unresectable local recurrent rectal cancer
Carbon ion radiation therapy DT: 74Gy/20 fractions
patients with unresectable local recurrent rectal cancer will be treated with carbon ion radiation therapy as re-irradiation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Carbon ion radiation therapy DT: 74Gy/20 fractions
patients with unresectable local recurrent rectal cancer will be treated with carbon ion radiation therapy as re-irradiation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\) received a radical operation for their primary tumor and regional lymph nodes,
* 3\) received chemo-radiation or radiation in pelvic before CIRT,
* 4\) received re-irradiation by CIRT after their pelvic radiotherapy.
Exclusion Criteria
* 2\) time to the last radiotherapy was \<1 year,
* 3\) space between the lesion to organ at risk (OARs) (bladder or digestive tract) was too close (\<5 mm).
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xin Cai
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xin Cai
Deputy chief physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Proton and Heavy ion center
Shanghai, Pudong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPHIC-TR-CRC2021-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.